Product Images Pregabalin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 14 images provide visual information about the product associated with Pregabalin NDC 71610-820 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Label - 71610 0820 30

Label - 71610 0820 30

Aphena - Aphena

Aphena - Aphena

Chemical Structure - pregabalin 01

Chemical Structure - pregabalin 01

Figure 1 - pregabalin 02

Figure 1 - pregabalin 02

Figure 2 - pregabalin 03

Figure 2 - pregabalin 03

Figure 3 - pregabalin 04

Figure 3 - pregabalin 04

This information provides data on the percentage of patients who experienced improvement in pain levels after different treatment regimens involving Pregabalin dosages and a placebo. The percentages range from 0% to 100% across the various dosages of Pregabalin and the placebo.*

Figure 4 - pregabalin 05

Figure 4 - pregabalin 05

Figure 5 - pregabalin 06

Figure 5 - pregabalin 06

This data shows the percentage of patients who experienced improvement in pain compared to the baseline after taking different dosages of Pregabalin and placebo. The percentage of improvement is recorded at various intervals for Pregabalin 100 mg three times a day, Pregabalin 50 mg three times a day, and Placebo. The graph visually represents the efficacy of these treatments in reducing pain levels in patients.*

Figure 6 - pregabalin 07

Figure 6 - pregabalin 07

Figure 7 - pregabalin 08

Figure 7 - pregabalin 08

Figure 9 - pregabalin 09

Figure 9 - pregabalin 09

This text provides information on the percentage of patients experiencing improvement in pain after taking different doses of Pregabalin and Placebo. The doses mentioned are 600 mg, 450 mg, and 300 mg per day for Pregabalin, with a comparison to Placebo. It also lists the percentage of improvement in pain from the baseline for each group.*

Figure 10 - pregabalin 10

Figure 10 - pregabalin 10

Figure 11 - pregabalin 11

Figure 11 - pregabalin 11

Figure 12 - pregabalin 12

Figure 12 - pregabalin 12

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.